Literature DB >> 7746697

The changing epidemiology of bacteremia in neutropenic children with cancer.

V M Aquino1, A Pappo, G R Buchanan, I Tkaczewski, M M Mustafa.   

Abstract

Gram-positive bacteria have been the predominant organisms causing bacteremia in febrile neutropenic cancer patients during the past decade. Recently we have noted an increase in Gram-negative bacteremia in children and adolescents with cancer. Therefore we retrospectively reviewed 153 episodes of bacteremia during a 6-year period to investigate changes in the etiology of bacteremia in pediatric oncology patients. In the early 3-year period (January, 1988, to December, 1990) Gram-positive organisms comprised 73 (74%) of the 99 isolates, and Staphylococcus epidermidis was the most common isolate. In the later 3-year period (January, 1991, to December, 1993) Gram-negative organisms were seen with greater frequency and represented 50% of isolates (P = 0.004). Pseudomonas aeruginosa was the most commonly isolated organism during this period (22% of all isolates). We speculate that the recent utilization of more intensive chemotherapy regimens has caused an alteration in the epidemiology of bacteremia in children and adolescents with cancer which could influence the initial empiric antibiotic regimens and the outcome of such infections.

Entities:  

Mesh:

Year:  1995        PMID: 7746697     DOI: 10.1097/00006454-199502000-00011

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Patterns and outcome of septicemia in neutropenic children with cancer in a Greek hospital.

Authors:  E Roilides; V Sidi; N Gompakis; M Tsivitanidou; A Katsaveli; D Koliouskas
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

2.  Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment.

Authors:  Katerina Katsimpardi; Vassilios Papadakis; Anastasia Pangalis; Agapi Parcharidou; John P Panagiotou; Michael Soutis; Evangelos Papandreou; Sophia Polychronopoulou; Stavros Haidas
Journal:  Support Care Cancer       Date:  2005-11-04       Impact factor: 3.603

Review 3.  Current guidelines for the treatment and prevention of nosocomial infections.

Authors:  E Bergogne-Bérézin
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

4.  Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia.

Authors:  E J Asturias; J E Corral; J Quezada
Journal:  Curr Oncol       Date:  2010-04       Impact factor: 3.677

Review 5.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

6.  Fever in neutropenia in children and adolescents: evolution over time of main characteristics in a single center, 1993-2001.

Authors:  Roland A Ammann; Christoph Aebi; Andreas Hirt; Annette Ridolfi Lüthy
Journal:  Support Care Cancer       Date:  2004-07-08       Impact factor: 3.603

7.  Outcome of bacteremia and fungemia in paediatric oncology patients.

Authors:  Joan L Robinson; Robert P Rennie
Journal:  Can J Infect Dis       Date:  2002-11

8.  Secular trends in pediatric bloodstream infections over a 20-year period at a tertiary care hospital in Germany.

Authors:  Markus Hufnagel; Anita Burger; Susanne Bartelt; Philipp Henneke; Reinhard Berner
Journal:  Eur J Pediatr       Date:  2008-01-30       Impact factor: 3.183

9.  A study of bacteremia in febrile neutropenic patients at a tertiary-care hospital with special reference to anaerobes.

Authors:  P Mathur; R Chaudhry; L Kumar; A Kapil; B Dhawan
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.